Stratos Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,924
| Closed | -$216K | – | 690 |
|
2025
Q1 | $216K | Buy |
+1,924
| New | +$216K | 0.01% | 614 |
|
2023
Q2 | – | Sell |
-3,328
| Closed | -$276K | – | 634 |
|
2023
Q1 | $276K | Buy |
3,328
+154
| +5% | +$12.8K | 0.02% | 507 |
|
2022
Q4 | $273K | Buy |
+3,174
| New | +$273K | 0.02% | 489 |
|
2022
Q3 | – | Sell |
-3,647
| Closed | -$225K | – | 506 |
|
2022
Q2 | $225K | Buy |
+3,647
| New | +$225K | 0.02% | 471 |
|
2022
Q1 | – | Sell |
-4,656
| Closed | -$338K | – | 541 |
|
2021
Q4 | $338K | Sell |
4,656
-387
| -8% | -$28.1K | 0.02% | 444 |
|
2021
Q3 | $352K | Sell |
5,043
-4,642
| -48% | -$324K | 0.03% | 408 |
|
2021
Q2 | $667K | Buy |
9,685
+4,599
| +90% | +$317K | 0.06% | 308 |
|
2021
Q1 | $329K | Buy |
5,086
+532
| +12% | +$34.4K | 0.03% | 379 |
|
2020
Q4 | $265K | Sell |
4,554
-198
| -4% | -$11.5K | 0.04% | 335 |
|
2020
Q3 | $300K | Sell |
4,752
-351
| -7% | -$22.2K | 0.07% | 254 |
|
2020
Q2 | $393K | Buy |
5,103
+1,294
| +34% | +$99.7K | 0.12% | 169 |
|
2020
Q1 | $285K | Buy |
3,809
+196
| +5% | +$14.7K | 0.2% | 112 |
|
2019
Q4 | $235K | Sell |
3,613
-210
| -5% | -$13.7K | 0.13% | 146 |
|
2019
Q3 | $242K | Buy |
3,823
+49
| +1% | +$3.1K | 0.09% | 218 |
|
2019
Q2 | $255K | Sell |
3,774
-109
| -3% | -$7.37K | 0.1% | 197 |
|
2019
Q1 | $252K | Sell |
3,883
-277
| -7% | -$18K | 0.14% | 177 |
|
2018
Q4 | $260K | Buy |
+4,160
| New | +$260K | 0.17% | 154 |
|